Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""CD4 Lymphocyte Count"" wg kryterium: Temat


Tytuł:
Accurate and reproducible enumeration of CD4 T cell counts and Hemoglobin levels using a point of care system: Comparison with conventional laboratory based testing systems in a clinical reference laboratory in Cameroon.
Autorzy:
Sagnia, Bertrand (AUTHOR)
Mbakop Ghomsi, Fabrice (AUTHOR)
Moudourou, Sylvie (AUTHOR)
Gutierez, Ana (AUTHOR)
Tchadji, Jules (AUTHOR)
Sosso, Samuel Martin (AUTHOR)
Ndjolo, Alexis (AUTHOR)
Colizzi, Vittorio (AUTHOR)
Pokaż więcej
Źródło:
PLoS ONE. 3/20/2024, Vol. 19 Issue 3, p1-11. 11p.
Czasopismo naukowe
Tytuł:
Clinical outcomes and risk factors for immune recovery and all-cause mortality in Latin Americans living with HIV with virological success: a retrospective cohort study.
Autorzy:
Castillo-Rozas G; Laboratory of Molecular and Cellular Virology, Institute of Biomedical Sciences, Faculty of Medicine, University of Chile, Santiago, Chile.; HIV/AIDS Workgroup, Faculty of Medicine, University of Chile, Santiago, Chile.
Tu S; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Luz PM; Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
Mejia F; Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Perú.
Sierra-Madero J; Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Ciudad de México, México.
Rouzier V; Groupe Haitien d'Etudes du Sarcome de Kaposi et des Infections Opportunistes, Port-au-Prince, Haiti.
Shepherd BE; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Cortes CP; HIV/AIDS Workgroup, Faculty of Medicine, University of Chile, Santiago, Chile.; Department of Internal Medicine, Faculty of Medicine, University of Chile, Santiago, Chile.; Hospital Clínico San Borja Arriarán & Fundación Arriarán, Santiago, Chile.; Millenium Institute on Immunology and Immunotherapy, Santiago, Chile.
Pokaż więcej
Źródło:
Journal of the International AIDS Society [J Int AIDS Soc] 2024 Mar; Vol. 27 (3), pp. e26214.
Typ publikacji:
Journal Article
MeSH Terms:
HIV Infections*
Acquired Immunodeficiency Syndrome*/drug therapy
Anti-HIV Agents*/therapeutic use
Humans ; Male ; Retrospective Studies ; Risk Factors ; Drug Therapy, Combination ; CD4 Lymphocyte Count ; Viral Load ; Antiretroviral Therapy, Highly Active
Czasopismo naukowe
Tytuł:
The association between single-nucleotide polymorphisms within type 1 interferon pathway genes and human immunodeficiency virus type 1 viral load in antiretroviral-naïve participants.
Autorzy:
Mørup SB; Centre of Excellence for Health, Immunity, and Infections, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Leung P; Centre of Excellence for Health, Immunity, and Infections, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Reilly C; Division of Biostatistics and Health Data Science, School of Public Health, University of Minnesota, Minneapolis, MN, USA.
Sherman BT; Laboratory of Human Retrovirology and Immunoinformatics, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
Chang W; Laboratory of Human Retrovirology and Immunoinformatics, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
Milojevic M; Centre of Excellence for Health, Immunity, and Infections, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Milinkovic A; Chelsea and Westminster Hospital NHS Foundation Trust, London, UK.
Liappis A; Washington DC Veterans Affairs Medical Center and The George Washington University School of Medicine and Health Sciences, Washington, DC, USA.
Borgwardt L; Center for Genomic Medicine, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Petoumenos K; Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia.
Paredes R; Department of Infectious Diseases and IrsiCaixa, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
Mistry SS; Division of Biostatistics and Health Data Science, School of Public Health, University of Minnesota, Minneapolis, MN, USA.
MacPherson CR; Centre of Excellence for Health, Immunity, and Infections, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.; Institut Roche, Boulogne-Billancourt, France.
Lundgren J; Centre of Excellence for Health, Immunity, and Infections, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.; Department of Infectious Diseases, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Helleberg M; Centre of Excellence for Health, Immunity, and Infections, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.; Department of Infectious Diseases, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Reekie J; Centre of Excellence for Health, Immunity, and Infections, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Murray DD; Centre of Excellence for Health, Immunity, and Infections, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark. .
Pokaż więcej
Corporate Authors:
INSIGHT FIRST and START study groups
Źródło:
AIDS research and therapy [AIDS Res Ther] 2024 May 03; Vol. 21 (1), pp. 27. Date of Electronic Publication: 2024 May 03.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
HIV Infections*/virology
HIV Infections*/genetics
HIV Infections*/immunology
HIV-1*/genetics
Polymorphism, Single Nucleotide*
Viral Load*
Interferon Type I*/genetics
Humans ; Male ; Female ; Adult ; Genotype ; Middle Aged ; Receptor, Interferon alpha-beta/genetics ; Cohort Studies ; Disease Progression ; CD4 Lymphocyte Count
Czasopismo naukowe
Tytuł:
HIV co-infection is associated with reduced Mycobacterium tuberculosis transmissibility in sub-Saharan Africa.
Autorzy:
Windels EM; Department of Biosystems Science and Engineering, ETH Zürich, Basel, Switzerland.; Swiss Tropical and Public Health Institute, Allschwil, Switzerland.; Swiss Institute of Bioinformatics, Lausanne, Switzerland.
Wampande EM; Makerere University, Kampala, Uganda.
Joloba ML; Makerere University, Kampala, Uganda.
Boom WH; Case Western Reserve University and University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States of America.
Goig GA; Swiss Tropical and Public Health Institute, Allschwil, Switzerland.; University of Basel, Basel, Switzerland.
Cox H; University of Cape Town, Cape Town, South Africa.
Hella J; Ifakara Health Institute, Dar es Salaam, Tanzania.
Borrell S; Swiss Tropical and Public Health Institute, Allschwil, Switzerland.; University of Basel, Basel, Switzerland.
Gagneux S; Swiss Tropical and Public Health Institute, Allschwil, Switzerland.; University of Basel, Basel, Switzerland.
Brites D; Swiss Tropical and Public Health Institute, Allschwil, Switzerland.; University of Basel, Basel, Switzerland.
Stadler T; Department of Biosystems Science and Engineering, ETH Zürich, Basel, Switzerland.; Swiss Institute of Bioinformatics, Lausanne, Switzerland.
Pokaż więcej
Źródło:
PLoS pathogens [PLoS Pathog] 2024 May 02; Vol. 20 (5), pp. e1011675. Date of Electronic Publication: 2024 May 02 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Mycobacterium tuberculosis*
HIV Infections*/complications
HIV Infections*/transmission
HIV Infections*/epidemiology
Coinfection*/microbiology
Coinfection*/epidemiology
Tuberculosis*/epidemiology
Tuberculosis*/transmission
Tuberculosis*/microbiology
Humans ; Africa South of the Sahara/epidemiology ; Male ; CD4 Lymphocyte Count ; Female ; Bayes Theorem ; Adult ; Risk Factors
Czasopismo naukowe
Tytuł:
Evaluation of the effects of Artemisia Annua L. and Moringa Oleifera Lam. on CD4 count and viral load among PLWH on ART at Mbarara Regional Referral Hospital: a double-blind randomized controlled clinical trial.
Autorzy:
Twinomujuni SS; Department of Pharmacy, Mbarara University of Science and Technology, P.O. Box 1410, Mbarara, Uganda. .
Atukunda EC; Department of Pharmacy, Mbarara University of Science and Technology, P.O. Box 1410, Mbarara, Uganda.
Mukonzo JK; Department of Pharmacology and Therapeutics, School of Biomedical Sciences, College of Health Sciences, Makerere University, P.O. Box 7062, Kampala, Uganda.
Nicholas M; Department of Pharmacy, Mbarara University of Science and Technology, P.O. Box 1410, Mbarara, Uganda.
Roelofsen F; Action for Natural Medicine in the Tropics (ANAMED INTERNATIONAL), Winnenden, Germany.
Ogwang PE; Department of Pharmacy, Mbarara University of Science and Technology, P.O. Box 1410, Mbarara, Uganda.
Pokaż więcej
Źródło:
AIDS research and therapy [AIDS Res Ther] 2024 Apr 16; Vol. 21 (1), pp. 22. Date of Electronic Publication: 2024 Apr 16.
Typ publikacji:
Randomized Controlled Trial; Journal Article
MeSH Terms:
Anti-HIV Agents*/therapeutic use
Artemisia annua*
HIV Infections*
Moringa oleifera*
Humans ; Anti-Retroviral Agents/therapeutic use ; CD4 Lymphocyte Count ; Hospitals ; Referral and Consultation ; Uganda ; Viral Load ; Double-Blind Method
Czasopismo naukowe
Tytuł:
Predictors of severe hepatotoxicity among retroviral infected adults on HAART regimen in Ilubabor Zone, Southwest Ethiopia.
Autorzy:
Darge T; Department of Biomedical Sciences, College of Health Sciences, Mettu University, Mettu, Ethiopia. .
Babusha A; Department of Biomedical Sciences, College of Health Sciences, Mettu University, Mettu, Ethiopia.
Chilo D; Department of Pharmacy, College of Health Sciences, Mettu University, Mettu, Ethiopia.
Dukessa A; Department of Biomedical Sciences, Institution of Health, Jimma University, Jimma, Ethiopia.
Teferi S; Department of Medical Laboratory Science, College of Health Sciences, Mettu University, Mettu, Ethiopia.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Apr 11; Vol. 14 (1), pp. 8473. Date of Electronic Publication: 2024 Apr 11.
Typ publikacji:
Journal Article
MeSH Terms:
HIV Infections*/complications
HIV Infections*/drug therapy
HIV Infections*/epidemiology
Coinfection*
Hepatitis C*/drug therapy
Liver Diseases*/etiology
Tuberculosis*/drug therapy
Drug-Related Side Effects and Adverse Reactions*/etiology
Digestive System Diseases*/drug therapy
Chemical and Drug Induced Liver Injury*/epidemiology
Chemical and Drug Induced Liver Injury*/etiology
Chemical and Drug Induced Liver Injury*/drug therapy
Adult ; Humans ; Antiretroviral Therapy, Highly Active/adverse effects ; Ethiopia/epidemiology ; Cross-Sectional Studies ; HIV ; Hepacivirus ; CD4 Lymphocyte Count
Czasopismo naukowe
Tytuł:
Late presentations and missed opportunities among newly diagnosed HIV patients presenting to a specialty clinic in Lebanon.
Autorzy:
Mahmoud M; Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
Ballouz T; Epidemiology, Biostatistics and Prevention Institute (EBPI), University of Zurich (UZH), Zurich, Switzerland.
Lahoud C; Faculty of Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
Adnan J; Faculty of Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
Habib PA; Faculty of Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
Saab R; Faculty of Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
Farhat H; Faculty of Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
Hussein ME; Faculty of Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
Rizk N; Division of Infectious Diseases, Department of Internal Medicine, American University of Beirut Medical Center, Riad El Solh, Beirut, 1107 2020, Lebanon. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Apr 09; Vol. 14 (1), pp. 8296. Date of Electronic Publication: 2024 Apr 09.
Typ publikacji:
Journal Article
MeSH Terms:
HIV Infections*/diagnosis
HIV Infections*/epidemiology
Acquired Immunodeficiency Syndrome*
Sexual and Gender Minorities*
HIV Seropositivity*
Male ; Adult ; Humans ; Female ; Homosexuality, Male ; HIV ; Retrospective Studies ; Risk Factors ; Lebanon/epidemiology ; Delayed Diagnosis ; CD4 Lymphocyte Count
Czasopismo naukowe
Tytuł:
Factors Associated with Neutralizing Antibody Responses following 2-Dose and 3rd Booster Monovalent COVID-19 Vaccination in Japanese People Living with HIV.
Autorzy:
Ngare I; Joint Research Center for Human Retrovirus Infection, Kumamoto University, 2-2-1 Honjo, Chuo-ku, Kumamoto 860-8555, Japan.; Graduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Chuo-ku, Kumamoto 860-0811, Japan.
Tan TS; Joint Research Center for Human Retrovirus Infection, Kumamoto University, 2-2-1 Honjo, Chuo-ku, Kumamoto 860-8555, Japan.
Toyoda M; Joint Research Center for Human Retrovirus Infection, Kumamoto University, 2-2-1 Honjo, Chuo-ku, Kumamoto 860-8555, Japan.
Kuwata T; Joint Research Center for Human Retrovirus Infection, Kumamoto University, 2-2-1 Honjo, Chuo-ku, Kumamoto 860-8555, Japan.
Takahama S; NHO, Kyushu Medical Center, 1-8-1 Jigyohama, Chuo-ku, Fukuoka 810-8563, Japan.
Nakashima E; NHO, Kyushu Medical Center, 1-8-1 Jigyohama, Chuo-ku, Fukuoka 810-8563, Japan.
Yamasaki N; Division of Transfusion Medicine, Hiroshima University Hospital, 1-2-3, Kasumi, Minami-ku, Hiroshima 734-8551, Japan.
Motozono C; Joint Research Center for Human Retrovirus Infection, Kumamoto University, 2-2-1 Honjo, Chuo-ku, Kumamoto 860-8555, Japan.
Fujii T; Division of Transfusion Medicine, Hiroshima University Hospital, 1-2-3, Kasumi, Minami-ku, Hiroshima 734-8551, Japan.
Minami R; NHO, Kyushu Medical Center, 1-8-1 Jigyohama, Chuo-ku, Fukuoka 810-8563, Japan.
Barabona G; Joint Research Center for Human Retrovirus Infection, Kumamoto University, 2-2-1 Honjo, Chuo-ku, Kumamoto 860-8555, Japan.
Ueno T; Joint Research Center for Human Retrovirus Infection, Kumamoto University, 2-2-1 Honjo, Chuo-ku, Kumamoto 860-8555, Japan.; Graduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Chuo-ku, Kumamoto 860-0811, Japan.; Joint Research Center for Human Retrovirus Infection, Kagoshima University, 8-35-1, Sakuragaoka, Kagoshima 890-8544, Japan.
Pokaż więcej
Źródło:
Viruses [Viruses] 2024 Apr 02; Vol. 16 (4). Date of Electronic Publication: 2024 Apr 02.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antibodies, Neutralizing*/blood
Antibodies, Neutralizing*/immunology
Antibodies, Viral*/blood
Antibodies, Viral*/immunology
COVID-19*/immunology
COVID-19*/prevention & control
SARS-CoV-2*/immunology
HIV Infections*/immunology
Immunization, Secondary*
COVID-19 Vaccines*/immunology
COVID-19 Vaccines*/administration & dosage
East Asian People*
Humans ; Male ; Female ; Middle Aged ; Adult ; Japan ; Aged ; Vaccination ; CD4 Lymphocyte Count
SCR Organism:
SARS-CoV-2 variants
Czasopismo naukowe
Tytuł:
Predictors of antiretroviral treatment failure to the first line therapy: a cross-sectional study among Iranian HIV-positive adults.
Autorzy:
Hashempour A; HIV/AIDS Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran.
Khodadad N; HIV/AIDS Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran.
Ziaei R; HIV/AIDS Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran.
Rezaei B; HIV/AIDS Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran.
Ghasabi F; HIV/AIDS Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran.
Falahi S; HIV/AIDS Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran.; Zoonotic Diseases Research Center, Ilam University of Medical Sciences, Ilam, Iran.
Kenarkouhi A; Department of Microbiology, Faculty of Medicine, Ilam University of Medical Sciences, Ilam, Iran.
Davarpanah MA; HIV/AIDS Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran. .; Department of Internal Medicine, Shiraz University of Medical Sciences, Shiraz, Iran. .
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2024 Mar 28; Vol. 24 (1), pp. 358. Date of Electronic Publication: 2024 Mar 28.
Typ publikacji:
Journal Article
MeSH Terms:
HIV Infections*
Anti-HIV Agents*
Adult ; Humans ; Iran ; Cross-Sectional Studies ; Anti-Retroviral Agents/therapeutic use ; Anti-Retroviral Agents/pharmacology ; Treatment Failure ; Viral Load ; CD4 Lymphocyte Count ; Antiretroviral Therapy, Highly Active
Czasopismo naukowe
Tytuł:
Association between smoking and lack of HIV virological suppression in a cross-sectional study of persons with HIV on antiretroviral therapy in Uganda.
Autorzy:
Tumwegamire A; Global Health Collaborative, Mbarara University of Science and Technology, Mbarara, Uganda.
Fatch R; Division of HIV, Infectious Disease and Global Medicine, University of California San Francisco, San Francisco, United States of America.
Emenyonu NI; Division of HIV, Infectious Disease and Global Medicine, University of California San Francisco, San Francisco, United States of America.
Lodi S; Boston University School of Public Health, Boston, Massachusetts, United States of America.
Muyindike WR; Global Health Collaborative, Mbarara University of Science and Technology, Mbarara, Uganda.; Mbarara Regional Referral Hospital, Mbarara, Uganda.
Kekibiina A; Global Health Collaborative, Mbarara University of Science and Technology, Mbarara, Uganda.
Adong J; Global Health Collaborative, Mbarara University of Science and Technology, Mbarara, Uganda.
Ngabirano C; Global Health Collaborative, Mbarara University of Science and Technology, Mbarara, Uganda.
Beesiga B; Infectious Diseases Research Collaboration, Kampala, Uganda.
Marson K; Division of HIV, Infectious Disease and Global Medicine, University of California San Francisco, San Francisco, United States of America.
Golabi N; Division of HIV, Infectious Disease and Global Medicine, University of California San Francisco, San Francisco, United States of America.
Kamya M; Infectious Diseases Research Collaboration, Kampala, Uganda.
Chamie G; Division of HIV, Infectious Disease and Global Medicine, University of California San Francisco, San Francisco, United States of America.
Hahn JA; Division of HIV, Infectious Disease and Global Medicine, University of California San Francisco, San Francisco, United States of America.; Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Mar 20; Vol. 19 (3), pp. e0300508. Date of Electronic Publication: 2024 Mar 20 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Alcoholism*/complications
HIV Infections*/complications
HIV Infections*/drug therapy
HIV Infections*/epidemiology
Anti-HIV Agents*/therapeutic use
Male ; Humans ; Adult ; Female ; Cross-Sectional Studies ; Smoking/epidemiology ; Uganda/epidemiology ; Anti-Retroviral Agents/therapeutic use ; CD4 Lymphocyte Count ; Ethanol/therapeutic use ; Viral Load
Czasopismo naukowe
Tytuł:
Difficult-to-treat HIV in Sweden: a cross-sectional study.
Autorzy:
Elvstam O; Department of Translational Medicine, Lund University, Malmö, Sweden. .; Department of Infectious Diseases, Växjö Central Hospital, Växjö, Sweden. .
Dahl V; Unit of Infectious Diseases/Venhälsan, Southern Hospital, Stockholm, Sweden.
Weibull Wärnberg A; Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden.
von Stockenström S; Gilead Sciences, Solna, Sweden.
Yilmaz A; Department of Infectious Diseases, Institute of Biomedicine, University of Gothenburg, Sahlgrenska Academy, Gothenburg, Sweden.; Department of Infectious Diseases, Sahlgrenska University Hospital, Region Västra Götaland, Gothenburg, Sweden.
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2024 Mar 18; Vol. 24 (1), pp. 325. Date of Electronic Publication: 2024 Mar 18.
Typ publikacji:
Journal Article
MeSH Terms:
Anti-HIV Agents*/therapeutic use
HIV Infections*/drug therapy
HIV Infections*/epidemiology
HIV-1*
Humans ; Female ; Cross-Sectional Studies ; Sweden/epidemiology ; CD4 Lymphocyte Count ; Viral Load ; Antiretroviral Therapy, Highly Active
Czasopismo naukowe
Tytuł:
Long-term HIV care outcomes under universal HIV treatment guidelines: A retrospective cohort study in 25 countries.
Autorzy:
Brazier E; City University of New York, Institute for Implementation Science in Population Health (ISPH), New York, New York, United States of America.; City University of New York, Graduate School of Public Health and Health Policy, New York, New York, United States of America.
Tymejczyk O; City University of New York, Institute for Implementation Science in Population Health (ISPH), New York, New York, United States of America.
Wools-Kaloustian K; Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, United States of America.
Jiamsakul A; The Kirby Institute, University of New South Wales, Sydney, Australia.
Torres MTL; Department of Pediatrics, Instituto Hondureño de Seguridad Social and Hospital Escuela Universitario, Tegucigalpa, Honduras.
Lee JS; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.
Abuogi L; Department of Pediatrics, University of Colorado School of Medicine and Children's Hospital Colorado, Aurora, Colorado, United States of America.
Khol V; National Center for HIV/AIDS, Dermatology and STDs, Phnom Penh, Cambodia.
Mejía Cordero F; Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Peru.
Althoff KN; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.
Law MG; The Kirby Institute, University of New South Wales, Sydney, Australia.
Nash D; City University of New York, Institute for Implementation Science in Population Health (ISPH), New York, New York, United States of America.; City University of New York, Graduate School of Public Health and Health Policy, New York, New York, United States of America.
Pokaż więcej
Corporate Authors:
International epidemiology Databases to Evaluate AIDS (IeDEA)
Źródło:
PLoS medicine [PLoS Med] 2024 Mar 18; Vol. 21 (3), pp. e1004367. Date of Electronic Publication: 2024 Mar 18 (Print Publication: 2024).
Typ publikacji:
Observational Study; Journal Article
MeSH Terms:
Anti-HIV Agents*/therapeutic use
HIV Infections*/drug therapy
HIV Infections*/epidemiology
Female ; Humans ; Adult ; Male ; Retrospective Studies ; Cohort Studies ; Proportional Hazards Models ; CD4 Lymphocyte Count
Czasopismo naukowe
Tytuł:
Factors influencing rapid antiretroviral therapy initiation in Jiulongpo, Chongqing, China: a retrospective cohort from 2018 to 2022.
Autorzy:
Chen C; Center for Disease Control and Prevention of Jiulongpo Distract, Chongqing, China.
Chen H; Center for Disease Control and Prevention of Jiulongpo Distract, Chongqing, China.
Wu L; Center for Disease Control and Prevention of Jiulongpo Distract, Chongqing, China.
Gong Q; Center for Disease Control and Prevention of Jiulongpo Distract, Chongqing, China.
He J; Center for Disease Control and Prevention of Jiulongpo Distract, Chongqing, China. .
Pokaż więcej
Źródło:
AIDS research and therapy [AIDS Res Ther] 2024 Mar 17; Vol. 21 (1), pp. 15. Date of Electronic Publication: 2024 Mar 17.
Typ publikacji:
Journal Article
MeSH Terms:
HIV Infections*/diagnosis
HIV Infections*/drug therapy
HIV Infections*/epidemiology
Anti-HIV Agents*/therapeutic use
Humans ; Male ; Female ; Middle Aged ; Retrospective Studies ; CD4 Lymphocyte Count ; China/epidemiology ; Proportional Hazards Models
Czasopismo naukowe
Tytuł:
The trajectories of CD4 T lymphocytes over time in patients who have defaulted on treatment for tuberculosis in a cohort of people living with HIV, Recife/PE.
Autorzy:
Cunha R; Postgraduate Program in Tropical Medicine, Universidade Federal de Pernambuco, Recife, Brazil.
Filho DBM; Postgraduate Program in Health Sciences, Universidade de Pernambuco, Recife, Brazil.
M Albuquerque MFP; Aggeu Magalhães Research Center (CPqAM), FIOCRUZ, Recife, Brazil.
Lacerda HR; Postgraduate Program in Tropical Medicine, Universidade Federal de Pernambuco, Recife, Brazil.
Diniz GTN; NEG-Aggeu Magalhães Research Center, Fundação Oswaldo Cruz, Recife, Brazil.
Montarroyos UR; Institute of Biological Sciences, Universidade de Pernambuco, Recife, Brazil.
Rodrigues LC; Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Vilela Moura LCR; Postgraduate Program in Tropical Medicine, Universidade Federal de Pernambuco, Recife, Brazil.
Ximenes RAA; Postgraduate Program in Tropical Medicine, Universidade Federal de Pernambuco, Recife, Brazil.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Mar 13; Vol. 19 (3), pp. e0299244. Date of Electronic Publication: 2024 Mar 13 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
HIV Infections*/complications
HIV Infections*/drug therapy
Tuberculosis*/drug therapy
Tuberculosis*/complications
Tuberculosis, Pulmonary*/drug therapy
Tuberculosis, Pulmonary*/complications
Humans ; CD4-Positive T-Lymphocytes ; CD4 Lymphocyte Count ; Anti-Retroviral Agents/therapeutic use
Czasopismo naukowe
Tytuł:
Factors associated with immunological non-response after ART initiation: a retrospective observational cohort study.
Autorzy:
Zhao, Heping (AUTHOR)
Feng, Anping (AUTHOR)
Luo, Dan (AUTHOR)
Yuan, Tanwei (AUTHOR)
Lin, Yi-Fan (AUTHOR)
Ling, Xuemei (AUTHOR)
Zhong, Huolin (AUTHOR)
Li, Junbin (AUTHOR)
Li, Linghua (AUTHOR)
Zou, Huachun (AUTHOR)
Pokaż więcej
Źródło:
BMC Infectious Diseases. 1/29/2024, Vol. 24 Issue 1, p1-9. 9p.
Czasopismo naukowe
Tytuł:
Mortality and associated factors among people living with HIV admitted at a tertiary-care hospital in Uganda: a cross-sectional study.
Autorzy:
Owachi D; Kiruddu National Referral Hospital, Kampala, P.O. BOX 6588, Uganda. .
Akatukunda P; Makerere University Joint AIDS Program, Kampala, Uganda.
Nanyanzi DS; Makerere University Joint AIDS Program, Kampala, Uganda.
Katwesigye R; Makerere University Joint AIDS Program, Kampala, Uganda.
Wanyina S; Makerere University Joint AIDS Program, Kampala, Uganda.
Muddu M; Makerere University Joint AIDS Program, Kampala, Uganda.
Kawuma S; Makerere University Joint AIDS Program, Kampala, Uganda.
Kalema N; Infectious Diseases Institute, Kampala, Uganda.
Kabugo C; Kiruddu National Referral Hospital, Kampala, P.O. BOX 6588, Uganda.
Semitala FC; Makerere University Joint AIDS Program, Kampala, Uganda.; Department of Medicine, Makerere University, Kampala, Uganda.
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2024 Feb 22; Vol. 24 (1), pp. 239. Date of Electronic Publication: 2024 Feb 22.
Typ publikacji:
Journal Article
MeSH Terms:
Coinfection*/drug therapy
HIV Infections*/drug therapy
HIV Infections*/epidemiology
Liver Diseases*/drug therapy
Anti-HIV Agents*/therapeutic use
Humans ; Female ; Adult ; Male ; Cross-Sectional Studies ; Uganda/epidemiology ; Tertiary Care Centers ; Hospitalization ; CD4 Lymphocyte Count
Czasopismo naukowe
Tytuł:
Disturbances in the IgG Antibody Profile in HIV-Exposed Uninfected Infants Associated with Maternal Factors.
Autorzy:
Camacho-Pacheco RT; Infectology and Immunology Department, National Institute of Perinatology (INPer), Mexico City, Mexico.; Departamento de Inmunología, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Ciudad de México, Mexico.; Posgrado en Inmunología, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Mexico City, Mexico.
Hernández-Pineda J; Infectology and Immunology Department, National Institute of Perinatology (INPer), Mexico City, Mexico.
Brito-Pérez Y; Infectology and Immunology Department, National Institute of Perinatology (INPer), Mexico City, Mexico.
Plazola-Camacho N; Infectology and Immunology Department, National Institute of Perinatology (INPer), Mexico City, Mexico.
Coronado-Zarco IA; Neonatology Department, National Institute of Perinatology (INPer), Mexico City, Mexico.
Arreola-Ramírez G; Neonatology Department, National Institute of Perinatology (INPer), Mexico City, Mexico.
Bermejo-Haro MY; Infectology and Immunology Department, National Institute of Perinatology (INPer), Mexico City, Mexico.; Departamento de Inmunología, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Ciudad de México, Mexico.; Posgrado en Inmunología, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Mexico City, Mexico.
Najera-Hernández MA; Infectology and Immunology Department, National Institute of Perinatology (INPer), Mexico City, Mexico.
González-Pérez G; Department of Physiology and Cellular Development, National Institute of Perinatology (INPer), Mexico City, Mexico.
Herrera-Salazar A; Unidad de Investigación Multidisciplinaria, Facultad de Estudios Superiores Cuautitlán, UNAM, Cuautitlán Izcalli, Mexico.
Olmos-Ortiz A; Immunobiochemistry Department, National Institute of Perinatology (INPer), Mexico City, Mexico.
Soriano-Becerril D; Infectology and Immunology Department, National Institute of Perinatology (INPer), Mexico City, Mexico.
Sandoval-Montes C; Departamento de Inmunología, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Ciudad de México, Mexico.
Figueroa-Damian R; Infectology and Immunology Department, National Institute of Perinatology (INPer), Mexico City, Mexico.
Rodríguez-Martínez S; Departamento de Inmunología, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Ciudad de México, Mexico.
Mancilla-Herrera I; Infectology and Immunology Department, National Institute of Perinatology (INPer), Mexico City, Mexico.
Pokaż więcej
Źródło:
Journal of immunology research [J Immunol Res] 2024 Feb 12; Vol. 2024, pp. 8815767. Date of Electronic Publication: 2024 Feb 12 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
HIV Infections*
Infant ; Humans ; Infant, Newborn ; Immunoglobulin G ; Incidence ; CD4 Lymphocyte Count ; Infectious Disease Transmission, Vertical
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies